Stryker Debt-to-EBITDA Ratio Growth & History (SYK)
Stryker's debt-to-ebitda ratio was 2.53 for fiscal 2025.
View full Stryker company overviewStryker annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.53 | −0.23 | −8.25% |
| 2024 | 2024-12-31 | 2.76 | 0.18 | +6.97% |
| 2023 | 2023-12-31 | 2.58 | −0.70 | −21.41% |
| 2022 | 2022-12-31 | 3.28 | −0.06 | −1.85% |
| 2021 | 2021-12-31 | 3.35 | −1.03 | −23.48% |
| 2020 | 2020-12-31 | 4.37 | 1.32 | +43.14% |
| 2019 | 2019-12-31 | 3.05 | 0.24 | +8.54% |
| 2018 | 2018-12-31 | 2.81 | 0.53 | +22.99% |
| 2017 | 2017-12-31 | 2.29 | −0.07 | −3.12% |
| 2016 | 2016-12-31 | 2.36 | 0.73 | +44.81% |
| 2015 | 2015-12-31 | 1.63 | −0.54 | −24.78% |
| 2014 | 2014-12-31 | 2.17 | 0.60 | +38.64% |
| 2013 | 2013-12-31 | 1.56 | 0.77 | +97.70% |
| 2012 | 2012-12-31 | 0.79 | −0.02 | −3.02% |
| 2011 | 2011-12-31 | 0.82 | 0.34 | +72.68% |
| 2010 | 2010-12-31 | 0.47 | 0.46 | +5094.51% |
| 2009 | 2009-12-31 | 0.01 | −0.00 | −23.93% |
| 2008 | 2008-12-31 | 0.01 | — | — |
Stryker quarterly debt-to-ebitda ratio
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.16 | −1.21 | −35.98% |
| Q1 2026 | 2026-03-31 | 2.31 | −1.17 | −33.63% |
| Q4 2025 | 2025-12-31 | 2.53 | −0.23 | −8.25% |
| Q3 2025 | 2025-09-30 | 3.32 | 0.65 | +24.53% |
| Q2 2025 | 2025-06-30 | 3.37 | 1.15 | +51.96% |
| Q1 2025 | 2025-03-31 | 3.48 | 1.07 | +44.54% |
| Q4 2024 | 2024-12-31 | 2.76 | 0.18 | +6.97% |
| Q3 2024 | 2024-09-30 | 2.66 | −0.11 | −3.93% |
| Q2 2024 | 2024-06-30 | 2.22 | −0.69 | −23.70% |
| Q1 2024 | 2024-03-31 | 2.41 | −0.66 | −21.46% |
| Q4 2023 | 2023-12-31 | 2.58 | −0.70 | −21.41% |
| Q3 2023 | 2023-09-30 | 2.77 | −0.44 | −13.79% |
| Q2 2023 | 2023-06-30 | 2.91 | −0.68 | −18.94% |
| Q1 2023 | 2023-03-31 | 3.07 | −0.77 | −19.97% |
| Q4 2022 | 2022-12-31 | 3.28 | −0.06 | −1.85% |
| Q3 2022 | 2022-09-30 | 3.22 | −0.26 | −7.54% |
| Q2 2022 | 2022-06-30 | 3.59 | 0.30 | +9.09% |
| Q1 2022 | 2022-03-31 | 3.83 | −0.39 | −9.18% |
| Q4 2021 | 2021-12-31 | 3.35 | −1.03 | −23.48% |
| Q3 2021 | 2021-09-30 | 3.48 | −0.42 | −10.87% |
| Q2 2021 | 2021-06-30 | 3.29 | −0.84 | −20.27% |
| Q1 2021 | 2021-03-31 | 4.22 | 1.40 | +49.84% |
| Q4 2020 | 2020-12-31 | 4.37 | 1.32 | +43.14% |
| Q3 2020 | 2020-09-30 | 3.90 | 1.37 | +54.22% |
| Q2 2020 | 2020-06-30 | 4.12 | 1.52 | +58.45% |
| Q1 2020 | 2020-03-31 | 2.82 | 0.26 | +10.29% |
| Q4 2019 | 2019-12-31 | 3.05 | 0.24 | +8.54% |
| Q3 2019 | 2019-09-30 | 2.53 | 0.46 | +22.49% |
| Q2 2019 | 2019-06-30 | 2.60 | 0.49 | +23.34% |
| Q1 2019 | 2019-03-31 | 2.55 | 0.10 | +3.91% |
| Q4 2018 | 2018-12-31 | 2.81 | 0.53 | +22.99% |
| Q3 2018 | 2018-09-30 | 2.07 | −0.28 | −11.83% |
| Q2 2018 | 2018-06-30 | 2.11 | −0.32 | −13.23% |
| Q1 2018 | 2018-03-31 | 2.46 | 0.06 | +2.51% |
| Q4 2017 | 2017-12-31 | 2.29 | −0.07 | −3.12% |
| Q3 2017 | 2017-09-30 | 2.34 | −0.06 | −2.50% |
| Q2 2017 | 2017-06-30 | 2.43 | −0.41 | −14.29% |
| Q1 2017 | 2017-03-31 | 2.40 | −0.51 | −17.54% |
| Q4 2016 | 2016-12-31 | 2.36 | 0.73 | +44.81% |
| Q3 2016 | 2016-09-30 | 2.40 | 0.87 | +56.98% |
| Q2 2016 | 2016-06-30 | 2.84 | 1.36 | +91.56% |
| Q1 2016 | 2016-03-31 | 2.91 | 1.26 | +76.14% |
| Q4 2015 | 2015-12-31 | 1.63 | −0.54 | −24.78% |
| Q3 2015 | 2015-09-30 | 1.53 | −0.70 | −31.36% |
| Q2 2015 | 2015-06-30 | 1.48 | −1.18 | −44.27% |
| Q1 2015 | 2015-03-31 | 1.65 | — | — |
| Q4 2014 | 2014-12-31 | 2.17 | 0.60 | +38.64% |
| Q3 2014 | 2014-09-30 | 2.23 | 0.60 | +36.71% |
| Q2 2014 | 2014-06-30 | 2.66 | 1.27 | +91.06% |
| Q4 2013 | 2013-12-31 | 1.56 | 0.77 | +97.70% |
| Q3 2013 | 2013-09-30 | 1.63 | 0.85 | +109.21% |
| Q2 2013 | 2013-06-30 | 1.39 | 0.61 | +78.41% |
| Q1 2013 | 2013-03-31 | 1.30 | 0.50 | +62.55% |
| Q4 2012 | 2012-12-31 | 0.79 | −0.02 | −3.02% |
| Q3 2012 | 2012-09-30 | 0.78 | −0.06 | −7.51% |
| Q2 2012 | 2012-06-30 | 0.78 | 0.30 | +61.93% |
| Q1 2012 | 2012-03-31 | 0.80 | 0.32 | +67.45% |
| Q4 2011 | 2011-12-31 | 0.82 | 0.34 | +72.68% |
| Q3 2011 | 2011-09-30 | 0.84 | 0.40 | +89.45% |
| Q2 2011 | 2011-06-30 | 0.48 | 0.00 | +0.42% |
| Q1 2011 | 2011-03-31 | 0.48 | −0.02 | −4.43% |
| Q4 2010 | 2010-12-31 | 0.47 | 0.46 | +5094.51% |
| Q3 2010 | 2010-09-30 | 0.45 | — | — |
| Q2 2010 | 2010-06-30 | 0.48 | — | — |
| Q1 2010 | 2010-03-31 | 0.50 | — | — |
| Q4 2009 | 2009-12-31 | 0.01 | — | — |
Stryker debt-to-ebitda ratio trends
Over the last five fiscal years, Stryker's debt-to-ebitda ratio decreased from 4.37 to 2.53, a change of −1.84. The latest reported quarter, Q2 2026, shows 2.16.
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stryker source filings ↗Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...